Search: onr:"swepub:oai:gup.ub.gu.se/322234" >
Juvenile mucopolysa...
Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
2022-10-08
-
Hindawi Limited,2022
Numbers
-
LIBRIS-ID:oai:gup.ub.gu.se/322234
-
https://gup.ub.gu.se/publication/322234URI
-
https://doi.org/10.1002/humu.24479DOI
Supplementary language notes
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
A rare and fatal disease resembling mucopolysaccharidosis in infants, is caused by impaired intracellular endocytic trafficking due to deficiency of core components of the intracellular membrane-tethering protein complexes, HOPS, and CORVET. Whole exome sequencing identified a novel VPS33A mutation in a patient suffering from a variant form of mucopolysaccharidosis. Electron and confocal microscopy, immunoblotting, and glycosphingolipid trafficking experiments were undertaken to investigate the effects of the mutant VPS33A in patient-derived skin fibroblasts. We describe an attenuated juvenile form of VPS33A-related syndrome-mucopolysaccharidosis plus in a man who is homozygous for a hitherto unknown missense mutation (NM_022916.4: c.599 G>C; NP_075067.2:p. Arg200Pro) in a conserved region of the VPS33A gene. Urinary glycosaminoglycan (GAG) analysis revealed increased heparan, dermatan sulphates, and hyaluronic acid. We showed decreased abundance of VPS33A in patient derived fibroblasts and provided evidence that the p.Arg200Pro mutation leads to destablization of the protein and proteasomal degradation. As in the infantile form of mucopolysaccharidosis plus, the endocytic compartment in the fibroblasts also expanded-a phenomenon accompanied by increased endolysosomal acidification and impaired intracellular glycosphingolipid trafficking. Experimental treatment of the patient's cultured fibroblasts with the proteasome inhibitor, bortezomib, or exposure to an inhibitor of glucosylceramide synthesis, eliglustat, improved glycosphingolipid trafficking. To our knowledge this is the first report of an attenuated juvenile form of VPS33A insufficiency characterized by appreciable residual endosomal-lysosomal trafficking and a milder mucopolysaccharidosis plus than the disease in infants. Our findings expand the proof of concept of redeploying clinically approved drugs for therapeutic exploitation in patients with juvenile as well as infantile forms of mucopolysaccharidosis plus disease.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Lev, D.
(author)
-
Michelson, M.
(author)
-
Yosovich, K.
(author)
-
Michaeli, H. G.
(author)
-
Bright, N. A.
(author)
-
Manna, Paul TGothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology
(author)
-
Dickson, V. K.
(author)
-
Tylee, K. L.
(author)
-
Church, H. J.
(author)
-
Luzio, J. P.
(author)
-
Cox, T. M.
(author)
-
Göteborgs universitetInstitutionen för neurovetenskap och fysiologi
(creator_code:org_t)
Related titles
-
In:Human Mutation: Hindawi Limited43:12, s. 2265-22781059-77941098-1004
Internet link
Find in a library
To the university's database
- By the author/editor
-
Pavlova, E. V.
-
Lev, D.
-
Michelson, M.
-
Yosovich, K.
-
Michaeli, H. G.
-
Bright, N. A.
-
show more...
-
Manna, Paul T
-
Dickson, V. K.
-
Tylee, K. L.
-
Church, H. J.
-
Luzio, J. P.
-
Cox, T. M.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Neurosciences
- Articles in the publication
-
Human Mutation
- By the university
-
University of Gothenburg